Also, a University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of ...

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce ...

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise ...

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring ...

ADP participated as a new investor in Thatch's $40 million Series B funding round in April, which brought the company's total ...

Med’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in ...

Healthcare leaders tell MobiHealthNews that 2026 will be the year artificial intelligence is put to the test. Executives across health systems, startups, big tech and investors predict a shift in AI ...

AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.